The TP53 gene status was determined to affect the sensitivity to RES as CRC cells with WT TP53 (HCT-116/p53 WT) were more sensitive to RES than cells with mutant TP53 (HCT-116/p53−/−). The gene discussed is TP53; the disease is colorectal carcinoma.